MetaVia (MTVA)

Profile

Full Name

MetaVia Inc.

Ticker Symbol

MTVA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 5, 2016

Indexes

Not included

Website

http://www.metaviatx.com

Employees

9

Key Details

Price

$0.73(-9.35%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.56(-44.72% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.73
MTVA price is $0.73

30-Day Relative Volume

1.40
MTVA 30-day relative volume is 1.40

Price Performance

Price Most recent change

-9.35%
MTVA price was down -9.35% on Apr 16, 2025

Price YTD change

-63.83%
MTVA price is down -63.83% since January 1st

Price 1-year change

-78.4%
MTVA price is down -78.4% year-on-year

Price 3-year change

-99.65%
MTVA price is down -99.65% over the past 3 years

Price Range

Price All-time high

$129540.00
MTVA price is currently -100.00% below its historical high of $129540.00

Price 3-year low

$0.71
MTVA price is currently +3.42% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$6.36M
MTVA market capitalization is $6.36 million

Market cap 3-year change

-72.57%
MTVA market capitalization is down -72.57% over the past 3 years

Market cap All-time high

$468.00M
MTVA market capitalization is currently -98.64% below its historical high of $468.00 million

Market cap sector rank

15.54%
MTVA market capitalization is higher than 15.54% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+76.41%
MTVA shares outstanding is up +76.41% year-on-year

Shares Outstanding 3-Year Change

+7690.19%
MTVA shares outstanding is up +7690.19% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.94
MTVA beta is 0.94

200-day SMA

$2.63
MTVA price is currently -72.11% below its 200-day simple moving average

50-day SMA

$1.53
MTVA price is currently -52.10% below its 50-day simple moving average

RSI

28.68
MTVA 14-day relative strength index is 28.68

Volume

1.40
MTVA 30-day relative volume is 1.40

ATR

$0.22
MTVA average true range is $0.22

10-day Historical Volatility

327.51%
MTVA 10-day historical volatility is 327.51%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
MTVA annual revenue value is unknown

Revenue Analysts estimate

-
MTVA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
MTVA annual revenue 1-year change is unknown

Revenue Sector rank

-
MTVA annual revenue is unknown

EPS

EPS

-$3.56
MTVA annual earnings per share is -$3.56

EPS Analysts estimate

-$2.61
MTVA annual earnings per share is currently +36.40% higher than the consensus analysts' forecast

EPS 1-year change

-44.72%
MTVA annual earnings per share is down -44.72% year-on-year

EPS Sector rank

25.54%
MTVA annual earnings per share is higher than 25.54% of companies in Healthcare sector

Profit

Gross profit

-
MTVA annual gross profit value is unknown

Gross margin

-
MTVA annual gross profit margin value is unknown

Operating profit

-$28.81M
MTVA annual operating income is -$28.81 million

Operating margin

-
MTVA annual operating profit margin value is unknown

Net income

-$27.59M
MTVA annual net profit is -$27.59 million

Net margin

-
MTVA annual net profit margin value is unknown

Expenses

Total expenses

$28.81M
MTVA annual total expenses is $28.81 million

Operating expenses

$28.81M
MTVA annual total operating expenses is $28.81 million

Cost of goods sold

-
MTVA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$7.26M
MTVA annual SGA is $7.26 million

Depreciation and amortization

$20.00K
MTVA annual depreciation & amortization is $20.00 thousand

Interest expense

-
MTVA annual interest expense value is unknown

Income tax

$0.00
MTVA annual income tax is $0.00

EBIT & EBITDA

EBIT

-$28.81M
MTVA annual earnings before interest & taxes is -$28.81 million

EBITDA

-$28.79M
MTVA annual EBITDA is -$28.79 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$16.26M
MTVA annual total assets is $16.26 million

Non current assets

$188.00K
MTVA annual long term assets is $188.00 thousand

Current assets

$16.07M
MTVA annual total current assets is $16.07 million

Cash and cash equivalents

$16.02M
MTVA annual cash & cash equivalents is $16.02 million

Accounts receivable

-
MTVA annual accounts receivable value is unknown

Inventory

-
MTVA annual inventory value is unknown

Liabilities

Total liabilities

$8.33M
MTVA annual total liabilities is $8.33 million

Long term liabilities

$58.00K
MTVA annual total long term liabilities is $58.00 thousand

Current liabilities

$8.27M
MTVA annual total current liabilities is $8.27 million

Accounts payable

$3.88M
MTVA annual accounts payable is $3.88 million

Debt

Total debt

$136.00K
MTVA annual total debt is $136.00 thousand

Total debt 1-year change

-33%
MTVA annual total debt is down -33% year-on-year

Long term debt

$58.00K
MTVA annual long term debt is $58.00 thousand

Short term debt

$78.00K
MTVA annual short term debt is $78.00 thousand

Equity & Capital

Shareholders equity

$7.93M
MTVA annual stockholders equity is $7.93 million

Book value

$7.93M
MTVA annual book value is $7.93 million

Retained earnings

-$135.86M
MTVA annual retained earnings is -$135.86 million

Working capital

$7.80M
MTVA annual working capital is $7.80 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$24.71M
MTVA annual cash flow from operations is -$24.71 million

Cash from operations 1-year change

-128.82%
MTVA annual cash flow from operations is down -128.82% year-on-year

Cash from investing

-$8000.00
MTVA annual cash flow from investing activities is -$8000.00

Cash from investing 1-year change

+84%
MTVA annual cash flow from investing activities is up +84% year-on-year

Cash from financing

$18.30M
MTVA annual cash flow from financing activities is $18.30 million

Cash from financing 1-year change

+22975%
MTVA annual cash flow from financing activities is up +22975% year-on-year

CAPEX

CAPEX

-
MTVA annual capital expenditures value is unknown

CAPEX 1-year change

-
MTVA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$24.72M
MTVA annual free cash flow is -$24.72 million

Free cash flow 1-year change

-127.84%
MTVA annual free cash flow is down -127.84% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
MTVA annual gross profit margin value is unknown

Operating margin

-
MTVA annual operating profit margin value is unknown

Net margin

-
MTVA annual net profit margin value is unknown

ROA & ROE

ROA

-169.69%
MTVA annual return on assets is -169.69%

ROE

-347.90%
MTVA annual return on equity is -347.90%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
MTVA price to earnings ratio value is unknown

PE ratio Sector rank

-
MTVA price to earnings ratio is unknown

PB Ratio

PB ratio

0.80
MTVA price to book ratio is 0.80

PB ratio Sector rank

40.16%
MTVA price to book ratio is higher than 40.16% of companies in Healthcare sector

PS Ratio

PS ratio

-
MTVA price to sales ratio value is unknown

PS ratio Sector rank

-
MTVA price to sales ratio is unknown

Enterprise value

Enterprise value

-$9.53M
MTVA enterprise value is -$9.53 million

Enterprise value Sector rank

5.13%
MTVA enterprise value is higher than 5.13% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.33
MTVA EV/EBITDA is 0.33

EV/EBITDA Sector rank

70.67%
MTVA EV/EBITDA is higher than 70.67% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.94
MTVA annual current ratio is 1.94

Quick ratio

-
MTVA annual quick ratio value is unknown

Leverage

Debt to equity

0.02
MTVA annual debt to equity ratio is 0.02

Interest coverage ratio

-
MTVA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
MTVA piotroski f-score value is unknown

Altman Z-Score

-
MTVA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 21, 25 HC Wainwright & Co.
Buy
Dec 30, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

Mobile-health Network Solutions Class A (MNDR)
NKGN logo
NKGen Biotech (NKGN)
PTN logo
Palatin Technologies (PTN)
INBS logo
Intelligent Bio Solutions (INBS)
AYTU logo
Aytu BioPharma (AYTU)
SSY logo
SunLink Health Systems (SSY)
Apollomics (APLM)
SNGX logo
Soligenix (SNGX)
CJJD logo
China Jo-Jo Drugstores (CJJD)
  • What is the ticker symbol for MetaVia?
  • Does MetaVia pay dividends?
  • What sector is MetaVia in?
  • What industry is MetaVia in?
  • What country is MetaVia based in?
  • When did MetaVia go public?
  • Is MetaVia in the S&P 500?
  • Is MetaVia in the NASDAQ 100?
  • Is MetaVia in the Dow Jones?
  • When was MetaVia's last earnings report?
  • When does MetaVia report earnings?
  • Should I buy MetaVia stock now?

What is the ticker symbol for MetaVia?

The ticker symbol for MetaVia is NASDAQ:MTVA

Does MetaVia pay dividends?

No, MetaVia does not pay dividends

What sector is MetaVia in?

MetaVia is in the Healthcare sector

What industry is MetaVia in?

MetaVia is in the Biotechnology industry

What country is MetaVia based in?

MetaVia is headquartered in United States

When did MetaVia go public?

MetaVia's initial public offering (IPO) was on August 5, 2016

Is MetaVia in the S&P 500?

No, MetaVia is not included in the S&P 500 index

Is MetaVia in the NASDAQ 100?

No, MetaVia is not included in the NASDAQ 100 index

Is MetaVia in the Dow Jones?

No, MetaVia is not included in the Dow Jones index

When was MetaVia's last earnings report?

MetaVia's most recent earnings report was on Mar 20, 2025

When does MetaVia report earnings?

The next expected earnings date for MetaVia is May 9, 2025

Should I buy MetaVia stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page